R&D/Clinical Trials

>

Latest News

Study: GLP-1, SGLT2s Linked to Reduced Alzheimer Disease Risk in Patients with Type 2 Diabetes
Study: GLP-1, SGLT2s Linked to Reduced Alzheimer Disease Risk in Patients with Type 2 Diabetes

April 17th 2025

A new study found that patients with type 2 diabetes treated with GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors demonstrated lower risks of developing Alzheimer disease compared to other glucose-lowering drugs.

New Insights Into T Cell Exhaustion and Inflammation in Long COVID
New Insights Into T Cell Exhaustion and Inflammation in Long COVID

April 17th 2025

ArkBio’s Ziresovir Demonstrates Clinical Efficacy in Hospitalized Infants with Respiratory Syncytial Virus
ArkBio’s Ziresovir Demonstrates Clinical Efficacy in Hospitalized Infants with Respiratory Syncytial Virus

April 16th 2025

Amgen’s Imdelltra Demonstrates Significant Overall Survival Improvement in Small Cell Lung Cancer
Amgen’s Imdelltra Demonstrates Significant Overall Survival Improvement in Small Cell Lung Cancer

April 16th 2025

Bristol Myers Squibb’s Camzyos Falls Short in Phase II Trial for Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Bristol Myers Squibb’s Camzyos Falls Short in Phase II Trial for Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

April 15th 2025

More News